Tower Research Capital (TRC)’s Citius Pharmaceuticals CTXR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,410
| Closed | -$6.57K | – | 5301 |
|
|
2025
Q1 | $6.57K | Sell |
4,410
-3,802
| -46% | -$5.67K | ﹤0.01% | 4032 |
|
|
2024
Q4 | $32.8K | Buy |
8,212
+8,050
| +4,969% | +$32.2K | ﹤0.01% | 2835 |
|
|
2024
Q3 | $2.02K | Sell |
162
-1,579
| -91% | -$19.7K | ﹤0.01% | 5060 |
|
|
2024
Q2 | $25.4K | Buy |
1,741
+1,413
| +431% | +$20.6K | ﹤0.01% | 3606 |
|
|
2024
Q1 | $7.35K | Sell |
328
-199
| -38% | -$4.46K | ﹤0.01% | 4220 |
|
|
2023
Q4 | $9.97K | Sell |
527
-129
| -20% | -$2.44K | ﹤0.01% | 4316 |
|
|
2023
Q3 | $11.2K | Buy |
656
+297
| +83% | +$5.08K | ﹤0.01% | 4021 |
|
|
2023
Q2 | $10.8K | Buy |
+359
| New | +$10.8K | ﹤0.01% | 4042 |
|
|
2023
Q1 | – | Sell |
-22
| Closed | – | – | 5875 |
|
|
2022
Q4 | $0 | Sell |
22
-137
| -86% | – | ﹤0.01% | 5950 |
|
|
2022
Q3 | $5K | Buy |
+159
| New | +$5K | ﹤0.01% | 5131 |
|
|
2022
Q2 | – | Sell |
-267
| Closed | -$12K | – | 6131 |
|
|
2022
Q1 | $12K | Sell |
267
-188
| -41% | -$8.45K | ﹤0.01% | 4049 |
|
|
2021
Q4 | $17K | Buy |
455
+80
| +21% | +$2.99K | ﹤0.01% | 3840 |
|
|
2021
Q3 | $19K | Sell |
375
-29
| -7% | -$1.47K | ﹤0.01% | 3750 |
|
|
2021
Q2 | $35K | Sell |
404
-1,610
| -80% | -$139K | ﹤0.01% | 3320 |
|
|
2021
Q1 | $90K | Buy |
+2,014
| New | +$90K | ﹤0.01% | 2668 |
|
|
2020
Q4 | – | Sell |
-337
| Closed | -$9K | – | 5155 |
|
|
2020
Q3 | $9K | Sell |
337
-772
| -70% | -$20.6K | ﹤0.01% | 4132 |
|
|
2020
Q2 | $31K | Buy |
+1,109
| New | +$31K | ﹤0.01% | 3412 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 3360 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 3608 |
|